LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Provided By GlobeNewswire
Last update: Mar 31, 2025
Pre-Clinical Study in Collaboration with Netherlands Cancer Institute
is in addition to LIXTE’s Ongoing Clinical Trials for Ovarian and Colorectal Cancers
NASDAQ:LIXTW (7/3/2025, 10:28:33 AM)
0.231
+0.01 (+5%)
NASDAQ:LIXT (7/3/2025, 10:29:08 AM)
2.655
+0.63 (+31.44%)
Find more stocks in the Stock Screener
